Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Research Methodology
Published in: BMC Medical Research Methodology 1/2016

Open Access 01-12-2016 | Study protocol

A virtual experimenter to increase standardization for the investigation of placebo effects

Authors: Bjoern Horing, Nathan D. Newsome, Paul Enck, Sabarish V. Babu, Eric R. Muth

Published in: BMC Medical Research Methodology | Issue 1/2016

Login to get access

Abstract

Background

Placebo effects are mediated by expectancy, which is highly influenced by psychosocial factors of a treatment context. These factors are difficult to standardize. Furthermore, dedicated placebo research often necessitates single-blind deceptive designs where biases are easily introduced. We propose a study protocol employing a virtual experimenter – a computer program designed to deliver treatment and instructions – for the purpose of standardization and reduction of biases when investigating placebo effects.

Methods

To evaluate the virtual experimenter’s efficacy in inducing placebo effects via expectancy manipulation, we suggest a partially blinded, deceptive design with a baseline/retest pain protocol (hand immersions in hot water bath). Between immersions, participants will receive an (actually inert) medication. Instructions pertaining to the medication will be delivered by one of three metaphors: The virtual experimenter, a human experimenter, and an audio/text presentation (predictor “Metaphor”). The second predictor includes falsely informing participants that the medication is an effective pain killer, or correctly informing them that it is, in fact, inert (predictor “Instruction”). Analysis will be performed with hierarchical linear modelling, with a sample size of N = 50. Results from two pilot studies are presented that indicate the viability of the pain protocol (N = 33), and of the virtual experimenter software and placebo manipulation (N = 48).

Discussion

It will be challenging to establish full comparability between all metaphors used for instruction delivery, and to account for participant differences in acceptance of their virtual interaction partner. Once established, the presence of placebo effects would suggest that the virtual experimenter exhibits sufficient cues to be perceived as a social agent. He could consequently provide a convenient platform to investigate effects of experimenter behavior, or other experimenter characteristics, e.g., sex, age, race/ethnicity or professional status. More general applications are possible, for example in psychological research such as bias research, or virtual reality research. Potential applications also exist for standardizing clinical research by documenting and communicating instructions used in clinical trials.
Literature
1.
Kelley JM, Lembo AJ, Ablon JS, Villanueva JJ, Conboy LA, Levy R, et al. Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med. 2009;71(7):789–97.CrossRefPubMedPubMedCentral
2.
Schedlowski M, Enck P, Rief W, Bingel U. Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice. Pharmacol Rev. 2015;1328:1–34.
3.
Vase L, Petersen GL, Riley JL, Price DD. Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain. 2009;145(1–2):36–44.CrossRefPubMed
4.
5.
Vase L, Robinson ME, Verne GN, Price DD. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients: an empirical investigation. Pain. 2003;105(1–2):17–25.CrossRefPubMed
6.
Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo response. Pain. 2011;151(2):430–9.CrossRef
7.
Hunter T, Siess F, Colloca L. Socially induced placebo analgesia: a comparison of a pre-recorded versus live face-to-face observation. Eur J Pain. 2014;18(7):914–22.CrossRefPubMed
8.
Kaptchuk TJ. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? J Clin Epidemiol. 2001;54(6):541–9.CrossRefPubMed
9.
Kienle GS, Kiene H. The powerful placebo effect: fact or fiction? J Clin Epidemiol. 1997;50(12):1311–8.CrossRefPubMed
10.
Hróbjartsson A, Kaptchuk TJ, Miller FG. Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol. 2011;64(11):1223–9.CrossRefPubMedPubMedCentral
11.
Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov. 2013;12(3):191–204.CrossRefPubMed
12.
Enck P, Klosterhalfen S, Weimer K, Horing B, Zipfel S. The placebo response in clinical trials: more questions than answers. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1889–95.CrossRefPubMedPubMedCentral
13.
Rohsenow DJ, Marlatt GA. The balanced placebo design: methodological considerations. Addict Behav. 1981;6(2):107–22.CrossRefPubMed
14.
Horing B, Weimer K, Schrade D, Muth ER, Scisco JL, Enck P, et al. Reduction of motion sickness with an enhanced placebo instruction: an experimental study with healthy participants. Psychosom Med. 2013;75(1534–7796):497–504.CrossRefPubMed
15.
Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17(10):1228–30.CrossRefPubMed
16.
Bingel U, Tracey I, Wiech K. Neuroimaging as a tool to investigate how cognitive factors influence analgesic drug outcomes. Neurosci Lett. 2012;520(2):149–55.CrossRefPubMed
17.
18.
di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. Lancet. 2001;357(9258):757–62.CrossRefPubMed
19.
Verheul W, Sanders A, Bensing J. The effects of physicians’ affect-oriented communication style and raising expectations on analogue patients’ anxiety, affect and expectancies. Patient Educ Couns. 2010;80(3):300–6.CrossRefPubMed
20.
Kállai I, Barke A, Voss U. The effects of experimenter characteristics on pain reports in women and men. Pain. 2004;112(1–2):142–7.CrossRefPubMed
21.
Aslaksen PM, Myrbakk IN, Høifødt RS, Flaten MA. The effect of experimenter gender on autonomic and subjective responses to pain stimuli. Pain. 2007;129(3):260–8.CrossRefPubMed
22.
Gratch J, Wang N, Okhmatovskaia A, Lamothe F, Morales M, van der Werf R, et al. Can virtual humans be more engaging than real ones? In: Jacko J, editor. Human-Computer Interaction, HCI Intelligent Multimodal Interaction Environments, Lecture Notes in Computer Science 4552. Berlin: Springer; 2007. p. 286–297.
23.
Triberti S, Repetto C, Riva G. Psychological factors influencing the effectiveness of virtual reality-based analgesia: a systematic review. Cyberpsychol Behav Soc Netw. 2014;17(6):335–45.CrossRefPubMed
24.
Hasler BS, Tuchman P, Friedman D. Virtual research assistants: replacing human interviewers by automated avatars in virtual worlds. Comput Human Behav. 2013;29(4):1608–16.CrossRef
25.
Racine M, Tousignant-Laflamme Y, Kloda LA, Dion D, Dupuis G, Choinire M. A systematic literature review of 10 years of research on sex/gender and experimental pain perception - Part 1: are there really differences between women and men? Pain. 2012;153(3):602–18.CrossRefPubMed
26.
Ledowski T, Stein J, Albus S, MacDonald B. The influence of age and sex on the relationship between heart rate variability, haemodynamic variables and subjective measures of acute post-operative pain. Eur J Anaesthesiol. 2011;28(6):433–7.CrossRefPubMed
27.
Bjørkedal E, Flaten MA. Expectations of increased and decreased pain explain the effect of conditioned pain modulation in females. J Pain Res. 2012;5:289–300.CrossRefPubMedPubMedCentral
28.
Felnhofer A, Kothgassner OD, Beutl L, Hlavacs H, Kryspin-Exner I. Is virtual reality made for men only? Exploring gender differences in the sense of presence. In: Annual conference of the international society on presence research. 2012.
29.
Horn C, Schaller J, Lautenbacher S. Investigating the affective component of pain: no startle modulation by tonic heat pain in startle responsive individuals. Int J Psychophysiol. 2012;84(3):254–9.CrossRefPubMed
30.
Rainville P, Duncan GH, Price DD, Carrier B, Bushnell MC. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science. 1997;277(5328):968–71.CrossRefPubMed
31.
Matre D, Casey KL, Knardahl S. Placebo-induced changes in spinal cord pain processing. J Neurosci. 2006;26(2):559–63.CrossRefPubMed
32.
Lyby PS, Aslaksen PM, Flaten MA. Is fear of pain related to placebo analgesia? J Psychosom Res. 2010;68(4):369–77.CrossRefPubMed
33.
Magerl W, Krumova EK, Baron R, Tölle T, Treede RD, Maier C. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain. 2010;151(3):598–605.CrossRefPubMed
34.
Horing B, Weimer K, Muth ER, Enck P. Prediction of placebo responses: a systematic review of the literature. Front Psychol. 2014;5(October):1–10.
35.
Loggia ML, Juneau M, Bushnell MC. Autonomic responses to heat pain: heart rate, skin conductance, and their relation to verbal ratings and stimulus intensity. Pain. 2011;152(3):592–8.CrossRefPubMed
36.
Streff A, Kuehl LK, Michaux G, Anton F. Differential physiological effects during tonic painful hand immersion tests using hot and ice water. Eur J Pain. 2010;14(3):266–72.CrossRefPubMed
37.
Saccò M, Meschi M, Regolisti G, Detrenis S, Bianchi L, Bertorelli M, et al. The relationship between blood pressure and pain. J Clin Hypertens. 2013;15(8):600–5.CrossRef
38.
Wu G, Campbell JN, Meyer RA. Effects of baseline skin temperature on pain ratings to suprathreshold temperature-controlled stimuli. Pain. 2001;90(1–2):151–6.CrossRefPubMed
39.
Myers MG, Valdivieso M, Kiss A. Optimum frequency of office blood pressure measurement using an automated sphygmomanometer. Blood Press Monit. 2008;13(6):333–8.CrossRefPubMed
40.
Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis. Thousand Oaks: Sage; 2002.
41.
Nielsen CS, Price DD, Vassend O, Stubhaug A, Harris JR. Characterizing individual differences in heat-pain sensitivity. Pain. 2005;119(1–3):65–74.CrossRefPubMed
42.
Tabachnick BG, Fidell LS. Using multivariate statistics. Harlow: Pearson; 2014.
43.
Hox JJ. Multilevel analysis: techniques and applications. 2nd ed. New York: Routledge; 2010.
44.
Fiske ST, Cuddy AJC, Glick P. Universal dimensions of social cognition: warmth and competence. Trends Cogn Sci. 2007;11(2):77–83.CrossRefPubMed
45.
Nass C, Moon Y. Machines and mindlessness: social responses to computers. J Soc Issues. 2000;56(1):81–103.CrossRef
46.
Blascovich J. A theoretical model of social influence for increasing the utility of collaborative virtual environments. In: Proceedings of the 4th international conference on collaborative virtual environments. New York: ACM Press; 2002. p. 25–30.CrossRef
47.
Gratch J, Okhmatovskaia A, Lamothe F, Marsella S, Morales M, van der Werf RJ, et al. Virtual rapport. In: Gratch J, Young M, Aylett R, Ballin D, Olivier P, editors. Intelligent virtual agents. Berlin, Heidelberg: Springer; 2006. p. 14–27.CrossRef
48.
Huang L, Morency L-P, Gratch J. Virtual rapport 2.0. In: Vilhjálmsson HH, Kopp S, Marsella S, Thórisson KR, editors. Intelligent virtual agents. Heidelberg: Springer; 2011. p. 68–79.CrossRef
49.
Babu SV, Schmugge S, Barnes T, Hodges LF, Babu SV, Schmugge S, Barnes T, Hodges LF. “What would you like to talk about?” an evaluation of social conversations with a virtual receptionist. In: Gratch J, Young M, Aylett R, Ballin D, Olivier P, editors. Intelligent virtual agents. Heidelberg: Springer; 2006. p. 169–80.CrossRef
50.
Mori M, MacDorman K, Kageki N. The uncanny valley [from the field]. IEEE Robot Autom Mag. 2012;19(2):98–100.CrossRef
51.
Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain. 1999;83(2):147–56.CrossRefPubMed
52.
Elsenbruch S, Kotsis V, Benson S, Rosenberger C, Reidick D, Schedlowski M, et al. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain. 2012;153(2):382–90.CrossRefPubMed
53.
Shah R, Ogden J. “What’s in a face?” the role of doctor ethnicity, age and gender in the formation of patients’ judgements: an experimental study. Patient Educ Couns Couns. 2006;60(2):136–41.CrossRef
54.
Bagozzi RP, Davis FD, Warshaw PR. Development and test of a theory of technological learning and usage. Hum Relations. 1992;45(7):659–86.CrossRef
55.
Weisband S, Kiesler S. Self disclosure on computer forms. In: Proceedings of the SIGCHI conference on human factors in computing systems. New York: ACM Press; 1996. p. 3–10.
56.
Joinson AN. Self-disclosure in computer-mediated communication: the role of self-awareness and visual anonymity. Eur J Soc Psychol. 2001;31(2):177–92.CrossRef
57.
Gratch J, Marsella S. Social emotions in nature and artifact. New York: Oxford University Press; 2013. p. 336.CrossRef
58.
Orne MT. On the social psychology of the psychological experiment: with particular reference to demand characteristics and their implications. Am Psychol. 1962;17(11):776–83.CrossRef
59.
Hughes J, Gabbay M, Funnell E, Dowrick C. Exploratory review of placebo characteristics reported in randomised placebo controlled antidepressant drug trials. Pharmacopsychiatry. 2012;45(1):20–7.CrossRefPubMed
60.
61.
de Carvalho ECA, Jayanti MK, Batilana AP, Kozan AMO, Rodrigues MJ, Shah J, et al. Standardizing clinical trials workflow representation in UML for international site comparison. PLoS One. 2010;5(11):e13893.CrossRefPubMedPubMedCentral
62.
Hróbjartsson A, Forfang E, Haahr MT, Als-Nielsen B, Brorson S. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. Int J Epidemiol. 2007;36(3):654–63.CrossRefPubMed
63.
Kenny P, Parsons T, Gratch J, Rizzo A. Virtual humans for assisted health care. In: Proceedings of the 1st ACM International Conference on PErvasive Technologies Related to Assistive Environments. New York: ACM Press; 2008. p. 1.
64.
Beauchamp TL, Childress JF. Principles of biomedical ethics. 7th ed. New York: Oxford University Press; 2013.
65.
66.
67.
68.
Martin AL, Katz J. Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain. Pain. 2010;149(2):208–15.CrossRefPubMed
69.
Schafer SM, Colloca L, Wager TD. Conditioned placebo analgesia persists when subjects know they are receiving a placebo. J Pain Elsevier Ltd. 2015;16(5):412–20.CrossRef
70.
Kisaalita N, Staud R, Hurley R, Robinson M. Placebo use in pain management: the role of medical context, treatment efficacy, and deception in determining placebo acceptability. Pain. 2014;155(12):2638–45.CrossRefPubMedPubMedCentral
71.
Cortez NG, Cohen IG, Kesselheim AS. FDA regulation of mobile health technologies. N Engl J Med. 2014;371(4):372–9.CrossRefPubMed
72.
73.
Metadata
Title
A virtual experimenter to increase standardization for the investigation of placebo effects
Authors
Bjoern Horing
Nathan D. Newsome
Paul Enck
Sabarish V. Babu
Eric R. Muth
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2016
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-016-0185-4

Other articles of this Issue 1/2016

BMC Medical Research Methodology 1/2016 Go to the issue

Research article

Mixed-strain housing for female C57BL/6, DBA/2, and BALB/c mice: validating a split-plot design that promotes refinement and reduction

Research article

How do researchers determine the difference to be detected in superiority trials? Results of a survey from a panel of researchers

Research article

Applicable or non-applicable: investigations of clinical heterogeneity in systematic reviews

Debate

Why sex and gender matter in implementation research

Research article

Bias of health estimates obtained from chronic disease and risk factor surveillance systems using telephone population surveys in Australia: results from a representative face-to-face survey in Australia from 2010 to 2013

Debate

Resuming the discussion of AMSTAR: What can (should) be made better?